Astellas Oncology

Astellas Oncology Industry Partnerships

Astellas Oncology adds value to its strategic alliances through its unique market position and expertise.



Astellas Oncology and Pfizer commercialize XTANDI® (enzalutamide) in the United States.

Visit Pfizer

Genentech, a member
of the Roche Group

Astellas Oncology and Genentech, a member of the Roche Group, jointly market Tarceva® (erlotinib) in the United States.

Visit Genentech

We believe collaboration between members of the cancer community brings leading treatments to patients who need them most.

Learn More About Partnering With Astellas

Mary Jo Struttmann
Executive Director of Alliance Management

Research Collaborations

Dana-Farber Cancer Institute

Astellas Oncology and Dana-Farber Cancer Institute have formed a collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer.

Visit Dana-Farber Cancer Institute

MD Anderson Cancer Center

Astellas Oncology and the University of Texas MD Anderson Cancer Center are collaborating to research and develop a new treatment for patients with acute myeloid leukemia.

Visit MD Anderson Cancer Center